Torti Frank
SEC CIK 1647805 · EDGAR
BoughtSold
Most active insiders at ROIV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MANCHESTER KEITH S | Dir | — | $154.47M |
| 2 | Gold Daniel Allen | Dir | — | $147.38M |
| 3 | QVT Financial LP | Dir by Deputization | — | $147.38M |
| 4 | Sukhatme Mayukh | Pres, CIO, Dir | — | $109.13M |
| 5 | Ramaswamy Vivek | 10% | — | $105.88M |
| 6 | Venker Eric | Pres, Immunovant CEO | — | $89.77M |
| 7 | Torti Frank | Pres, Vant COB | — | $82.04M |
| 8 | Gline Matthew | CEO, Dir | — | $46.17M |
| 9 | Pulik Richard | CFO | — | $9.12M |
| 10 | Fitzgerald Meghan | Dir | — | $3.27M |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 19:01 | 2026-06-30 | ROIV | Roivant Sciences Ltd. | Torti Frank | Pres, Vant COB | F - Tax | $35.39 | -40.3K | 13.54M | -0.3% | -$1.43M | |
| D | 2026-04-09 16:31 | 2026-04-07 | IMVT | Immunovant, Inc. | Torti Frank | Dir | A - Grant | $0.00 | +174.2K | 1.01M | +21% | $0 |
| 2026-04-02 19:14 | 2026-03-31 | ROIV | Roivant Sciences Ltd. | Torti Frank | Pres, Vant COB | F - Tax | $27.70 | -160.0K | 13.58M | -1% | -$4.43M | |
| DM | 2026-02-23 | 2026-02-19+ | ROIV | Roivant Sciences Ltd. | Torti Frank | Pres, Vant COB | M - OptEx | $3.85 | +3.00M | 14.75M | +26% | +$11.55M |
| DM | 2026-02-23 | 2026-02-19+ | ROIV | Roivant Sciences Ltd. | Torti Frank | Pres, Vant COB | S - Sale+OE | $27.35 | -3.00M | 13.74M | -18% | -$82.04M |
| 2025-12-29 | 2025-12-24 | ROIV | Roivant Sciences Ltd. | Torti Frank | Pres, Vant COB | J - Other | $22.47 | -64.9K | 13.85M | -0.5% | -$1.46M | |
| 2025-12-29 | 2025-12-24 | ROIV | Roivant Sciences Ltd. | Torti Frank | Pres, Vant COB | G - Gift | $0.00 | -110.5K | 13.74M | -0.8% | $0 | |
| 2025-12-29 | 2025-12-23 | ROIV | Roivant Sciences Ltd. | Torti Frank | Pres, Vant COB | A - Grant | $22.45 | +175.4K | 13.91M | +1% | +$3.94M | |
| M | 2025-08-01 | 2025-07-30 | ROIV | Roivant Sciences Ltd. | Torti Frank | Pres, Vant COB | A - Grant | $0.00 | +13.74M | 13.74M | New | $0 |
| D | 2025-04-03 | 2025-04-01 | IMVT | Immunovant, Inc. | Torti Frank | Dir | A - Grant | $0.00 | +199.4K | 835.0K | +31% | $0 |
| D | 2024-04-04 | 2024-04-02 | IMVT | Immunovant, Inc. | Torti Frank | Dir | A - Grant | $0.00 | +120.4K | 635.7K | +23% | $0 |
| D | 2023-04-14 | 2023-04-12 | IMVT | Immunovant, Inc. | Torti Frank | Dir | A - Grant | $0.00 | +121.9K | 515.3K | +31% | $0 |
| 2022-09-29 | 2022-09-29 | IMVT | Immunovant, Inc. | Torti Frank | Dir | P - Purchase | $5.81 | +20.0K | 393.4K | +5% | +$116.2K | |
| D | 2022-08-19 | 2022-08-17 | IMVT | Immunovant, Inc. | Torti Frank | Dir | A - Grant | $0.00 | +225.6K | 373.4K | +153% | $0 |
| D | 2022-01-12 | 2022-01-10 | IMVT | Immunovant, Inc. | Torti Frank | Dir | A - Grant | $0.00 | +100.1K | 147.7K | +210% | $0 |
Purchase Sale Sale after option exercise All abbreviations